Dr. Fadrowski performs clinical research in the area of chronic kidney disease in children. His specific research interests include the role of heavy metals, such as lead and cadmium, in the progression of chronic kidney disease; anemia in chronic kidney disease; and patient outcomes related to the various types of vascular access used for hemodialysis in children.
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil) in Girls and Young Women with Chronic Kidney Disease
Kuo CC, Weaver V, Fadrowski JJ, Lin YS, Guallar E, Navas-Acien A. "Arsenic exposure, hyperuricemia, and gout in US adults." Environ Int. 2015 Mar;76:32-40. doi: 10.1016/j.envint.2014.11.015. Epub
Yeh HC, Lin YS, Kuo CC, Weidemann D, Weaver V, Fadrowski J, Neu A, Navas-Acien A. "Urine osmolality in the US population: Implications for environmental biomonitoring." Environ Res. 2015 Jan;136:482-90. doi: 10.1016/j.envres.2014.09.009. Epub
Zheng L, Kuo CC, Fadrowski J, Agnew J, Weaver VM, Navas-Acien A. "Arsenic and Chronic Kidney Disease: A Systematic Review." Curr Environ Health Rep. 2014 Sep 1;1(3):192-207.
Sinclair EA, Yenokyan G, McMunn A, Fadrowski JJ, Milstone AM, Lee CK. "Factors associated with acute kidney injury in children receiving vancomycin." Ann Pharmacother. 2014 Dec;48(12):1555-62. doi: 10.1177/1060028014549185. Epub
Dahlinghaus EK, Neu AM, Atkinson MA, Fadrowski JJ. "Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis." Pediatr Nephrol. 2014 Dec;29(12):2387-94. doi: 10.1007/s00467-014-2872-x. Epub